Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy

Scandinavian Journal of Immunology

Volumn 74, Issue 4, 2011, Pages 335-341

  D'Arienzo, R ^a   Stefanile, R ^a   Maurano, F ^a   Mazzarella, G ^a   Ricca, E ^b   Troncone, R ^b   Auricchio, S ^b   Rossi, M ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN; IMMUNOMODULATING AGENT; INTERLEUKIN 2; PROBIOTIC AGENT; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD25+ T LYMPHOCYTE; CELL DENSITY; CONTROLLED STUDY; DRUG EFFECT; ENTEROPATHY; INTESTINE MUCOSA; LACTOBACILLUS CASEI; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WEIGHT REDUCTION;

ANIMALS; CELIAC DISEASE; CYTOKINES; GLIADIN; GLUTENS; HLA-DQ ANTIGENS; IMMUNOLOGIC FACTORS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; LACTOBACILLUS CASEI; MICE; MICE, TRANSGENIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 80052659382     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02582.x     Document Type: Article

References (35)

1. Axelsson L. Lactic acid bacteria: classification and physiology. In: Salminen S, Von Wright A, eds. Lactic Acid Bacteria: Microbiology and Functional Aspects, 2nd edn. New York: Marcel Dekker, Inc, 1998:1-72. ISBN: 978-0-8247-5332-0.
2. Kandler O, Weiss N. Genus Lactobacillus. In: Sneath PHA, Mair NS, Sharpe ME, Holt JG, eds. Bergey's Manual of Systematic Bacteriology, Vol. 2, 9th edn. Baltimore: Williams and Wilkins, 1986:1063-5. ISBN: 0-683-07893-3.
3. Tuohy M, Probert HM, Smejkal CW, Gibson GR. Using probiotics and prebiotics to improve gut health. Drug Discov Today 2003;8:692-700.
4. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996;64:5403-5.
5. Hessle C, Hanson LA, Wold AE. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 1999;116:276-82.
6. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002;168:171-8.
7. Mohamadzadeh M, Olson S, Kalina WV et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 2005;102:2880-5.
8. Morita H, He F, Fuse T et al. Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Biosci Biotechnol Biochem 2002;66:1963-6.
9. Biblioni R, Fedorak RN, Tannock GW et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005;100:1539-46.
10. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999;354:635-9.
11. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51.
12. Seegers JFML. Lactobacilli as live vaccine delivery vectors: progress and prospects. Trends Biotechnol 2002;20:508-15.
13. Mäki M, Mustalahti K, Kokkonen J et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517-24.
14. Sollid LM. Coeliac disease: dissetting a complex inflammatory disorder. Nat Rev Immunol, 2002;2:647-55.
15. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005;3:843-51.
16. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81.
17. Green PH, Jabri B. Coeliac disease. Lancet 2003;362:383-91.
18. MacDonald TT, Bajaj-Elliott M, Pender SL. T cells orchestrate intestinal mucosal shape and integrity. Immunol Today 1999;20:505-10.
19. Ferguson A, McClure JP, Townley RR. Intraepithelial lymphocyte counts in small intestinal biopsies from children with diarrhoea. Acta Paediatr Scand 1976;65:541-6.
20. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330-54.
21. Dieterich W, Enhis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
22. D'Arienzo R, Stefanile R, Maurano F et al. A deregulated immune response to gliadin causes a decreased villus height in DQ8 transgenic mice. Eur J Immunol 2009;39:3552-61.
23. Cheng S, Baisch J, Krco C et al. Expression and function of HLA-DQ8 (DQA1*0301/DQB1*0302) genes in transgenic mice. Eur J Immunogenet 1996;23:15-20.
24. D'Arienzo R, Maurano F, Luongo D et al. Adjuvant effect of lactobacillus casei in a mouse model of gluten sensitivity. Immunol Lett 2008;119:78-83.
25. Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol 2002;169:5595-600.
26. Senger S, Maurano F, Mazzeo MF et al. Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization. J Immunol 2005;175:8087-95.
27. Stepankova R, Tlaskalova-Hogenova H, Sinkora J, Jodi J, Fric P. Changes in jejunal mucosa after long-term feeding of germfree rats with gluten. Scand J Gastroenterol 1996;31:551-7.
28. Newberry RD, Stenson WF, Lorenz RG. Cycooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 1999;5:900-6.
29. Takeuchi K, Tanaka A, Ohno R, Yokota A. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. J Physiol Pharmacol 2003;54:165-82.
30. Aabakken L, Bjornbeth BA, Hofstad B, Olaussen B, Larsen S, Osnes M. Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric-coated tablets, or enteric-coated granules in capsules. Scand J Gastroenterol Suppl 1989;163:65-73.
31. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832-47.
32. Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Intern Med 1987;107:513-6.
33. D'Arienzo R, Maurano F, Lavermicocca P, Ricca E, Rossi M. Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity. Cytokine 2009;48:254-9.
34. Watanabe T, Nishio H, Tanigawa T et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol 2009;297:G506-13.
35. Uchida M, Shimizu K, Kurakazu K. Yogurt containing Lactobacillus gasseri OLL 2716 (LG21 yogurt) accelerated the healing of acetic acid-induced gastric ulcer in rats. Biosci Biotechnol Biochem 2010;74:1891-4.